Related Experiment Video
Updated: Jun 10, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Mixed pH-sensitive polymeric micelles for combination drug delivery
Younsoo Bae1, Adam W G Alani, Nicole C Rockich
1Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone, Lexington, Kentucky 40536-0596, USA. younsoo.bae@uky.edu
This study developed mixed polymeric micelles for dual-drug cancer chemotherapy, effectively suppressing tumor growth. These novel micelles offer a promising approach to enhance combination therapy efficacy.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Combination chemotherapy aims to improve treatment efficacy and overcome drug resistance.
- Polymeric micelles offer a versatile platform for drug delivery, encapsulating multiple therapeutic agents.
- Developing systems for co-delivery of doxorubicin (DOX) and 17-hydroxyethylamino-17-demethoxygeldanamycin (GDM-OH) is crucial for synergistic anticancer effects.
Purpose of the Study:
- To create mixed polymeric micelles capable of co-delivering doxorubicin (DOX) and 17-hydroxyethylamino-17-demethoxygeldanamycin (GDM-OH) for enhanced cancer chemotherapy.
- To investigate different methods for forming mixed micelles, including aqueous mixing and organic solvent evaporation.
- To evaluate the physicochemical properties and in vitro efficacy of the prepared mixed micelles.
Main Methods:
- pH-sensitive micelles were synthesized using poly(ethylene glycol)-poly(aspartate hydrazide) block copolymers.
- Doxorubicin (DOX) and GDM-OH were conjugated to the block copolymers via acid-labile hydrazone bonds.
- Mixed micelles were prepared by aqueous mixing of individual micelles or by co-dissolving block copolymers in mixed solvents followed by solvent evaporation.
- Characterization included particle size analysis, pH-dependent drug release studies, cytotoxicity assays, and western blot analysis.
Main Results:
- Individual and mixed polymeric micelles exhibited particle sizes below 100 nm, suitable for drug delivery.
- Drug release profiles were pH-dependent, indicating controlled release characteristics.
- Mixed polymer micelles demonstrated effective suppression of cancer cell growth in a manner dependent on drug concentration, mixing method, and administration schedule.
- Western blot analysis confirmed the biological activity of the delivered drugs.
Conclusions:
- Mixed polymeric micelles provide an effective platform for combination cancer chemotherapy.
- This approach appears to mitigate schedule-dependent variations in combination drug efficacy compared to traditional DMSO formulations.
- The developed system holds potential for improving the therapeutic outcomes of dual-drug cancer treatments.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Micelles
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed II
Bioavailability Enhancement: Drug Permeability Enhancement

